Projects per year
Fingerprint
Dive into the research topics where Sharad A Ghamande is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GHSU Minority-Based Community Clinical Oncology Program
Ghamande, S. A., Jillella, A., GHAMANDE, S., JILLELLA, A. & KALLAB, A.
Project: Research project
-
-
MCG Minority-Based Community Clinical Oncology Program
Jillella, A., Ghamande, S. A., JILLELLA, A. P., JILLELLA, A. P., GHAMANDE, S., KALLAB, A., JILLELLA, A. P. & KALLAB, A. M.
Project: Research project
-
-
Pharmacogenetics as a predictor chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy
Mysona, D., Dorr, K., Ward, A., Shaver, E., Rungruang, B. & Ghamande, S., Jan 2023, In: Gynecologic Oncology. 168, p. 114-118 5 p.Research output: Contribution to journal › Article › peer-review
-
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study
Moore, K. N., Chambers, S. K., Hamilton, E. P., Chen, L. M., Oza, A. M., Ghamande, S. A., Konecny, G. E., Plaxe, S. C., Spitz, D. L., Geenen, J. J. J., Troso-Sandoval, T. A., Cragun, J. M., Rodrigo Imedio, E., Kumar, S., Mugundu, G. M., Lai, Z., Chmielecki, J., Jones, S. F., Spigel, D. R. & Cadoo, K. A., Jan 1 2022, In: Clinical Cancer Research. 28, 1, p. 36-44 9 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
Monk, B. J., Parkinson, C., Lim, M. C., O'malley, D. M., Oaknin, A., Wilson, M. K., Coleman, R. L., Lorusso, D., Bessette, P., Ghamande, S., Christopoulou, A., Provencher, D., Prendergast, E., Demirkiran, F., Mikheeva, O., Yeku, O., Chudecka-Glaz, A., Schenker, M., Littell, R. D., Safra, T., & 19 others, May 1 2022, In: Journal of Clinical Oncology. 381, JCO.22.01003.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial
Lee, J. M., Moore, R. G., Ghamande, S., Park, M. S., Diaz, J. P., Chapman, J., Kendrick, J., Slomovitz, B. M., Tewari, K. S., Lowe, E. S., Milenkova, T., Kumar, S., Dymond, M., Brown, J. & Liu, J. F., Oct 1 2022, In: Clinical Cancer Research. 28, 19, p. 4186-4193 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical calculator redefines prognosis for high-risk early-stage ovarian cancers and potential to guide treatment in the adjuvant setting
Bui, A., Gehrig, P. A., Ghamande, S., Rungruang, B. J., Chan, J. K. & Mysona, D. P., Nov 2022, In: Gynecologic Oncology. 167, 2, p. 205-212 8 p.Research output: Contribution to journal › Article › peer-review